重大事件
即時報告
8-K
2026-06-02
Oncolytics Biotech Inc. 於2026年6月2日向SEC提交8-K即時報告，主要涉及兩項重大事件：
AI 繁中摘要
Oncolytics Biotech Inc. 於2026年6月2日向SEC提交8-K即時報告，主要涉及兩項重大事件：
📌 **Item 5.02：董事或高級職員變動及補償安排**
公司宣佈董事會（BOD）及/或首席運營官（COO）出現人事調動，並公布相關補償方案。具體細節載於附件EX-99.1（文件名：oncybodandcoo.htm），包括新任或離任人員的聘任條件、薪酬調整等。
📌 **Item 8.01：其他事件**
報告同時包含一項未被歸類於其他條款的重要公司事件，惟文件中未詳細披露具體內容，投資者需參閱完整申報文件以了解全貌。
此次8-K申報未提供具體財務數字，但人事變動（尤其COO層級）可能影響公司營運方向及執行力。Oncolytics為專注腫瘤藥品研發的生物科技公司，領導層變動或對研發管線、合作談判產生潛在影響。建議投資者仔細閱讀原文附件及後續公告。🔍
展開英文正文
EDGAR Filing Documents for 0001129928-26-000039 SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0001129928-26-000039 Filing Date 2026-06-02 Accepted 2026-06-02 09:02:48 Documents 12 Period of Report 2026-06-02 Items Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 8.01: Other Events Interactive Data Document Format Files Seq Description Document Type Size 1 8-K oncy-20260602.htm iXBRL 8-K 39209 2 EX-99.1 oncybodandcoo.htm EX-99.1 9459 Complete submission text file 0001129928-26-000039.txt 168629 Data Files Seq Description Document Type Size 3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT oncy-20260602.xsd EX-101.SCH 1812 4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT oncy-20260602_lab.xml EX-101.LAB 21597 5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT oncy-20260602_pre.xml EX-101.PRE 12516 16 EXTRACTED XBRL INSTANCE DOCUMENT oncy-20260602_htm.xml XML 2811 Mailing Address SUITE 325, 4350 EXECUTIVE DRIVE SAN DIEGO CA 92121 Business Address SUITE 325, 4350 EXECUTIVE DRIVE SAN DIEGO CA 92121 4036707377 ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings) EIN.: 980541667 | State of Incorp.: NV | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-38512 | Film No.: 261053818 SIC: 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)